Category survey

Fe65/APP signalling and brain-derived neurotrophic factor in Alzheimer’s disease Investments < €500k United Kingdom 2016    

Alterations in autophagy in frontotemporal lobar degeneration: identifying new targets for therapeutic intervention Investments < €500k United Kingdom 2016    

CRACK IT – UnTangle Challenge Investments < €500k United Kingdom 2016    

Tau Phosphorylation and Beta Amyloid Production in 1,25 MARRS Gene Silenced Neurons Investments < €500k Turkey 2016    

Use of Nanopattern Polycarbonate Surfaces in Alzheimer’s Disease Diagnosis Investments < €500k Turkey 2016    

Neurodegenerative Effect of Fe3O4 and Graphene Based Peptides in in vitro and in vivo Parkinson’s Models Investments < €500k Turkey 2016    

AKR1B1 Inhibitors in Diabetes, Inflammation and Age Dependent Neurodegeneration Investments < €500k Turkey 2016    

MPP+ Parkinson’s Disease Model Investments < €500k Turkey 2016    

Metagenomic Analysis of the Relationship Between Alzheimer’s Disease and Intestinal Microbiome Investments < €500k Turkey 2016    

miRNAs as a Neurodegeneration Risk Factor in Boxers Investments < €500k Turkey 2016    

Amyloid Based Bioactive Membrane Production Investments < €500k Turkey 2016    

The relationship between PAF acetylhydrolase, paraoxonase and serum amyloid A in preeclempsia Investments < €500k Turkey 2016    

Brain Oscillations as a Biomarker in Alzheimer’s Disease Investments < €500k Turkey 2016    

BRAINet: Composite Network Modeling of Neurological/Psychiatric Disorders and Application to Alzheimer’s Disease Investments < €500k Turkey 2016    

Standardization of a Screening Test for Dementia and Biomarker Research Investments < €500k Turkey 2016    

Contribution of TREM2 and neuroinflammation to neurodegeneration and cognitive dysfunction in response to chronic cerebral hypoperfusion Investments < €500k United Kingdom 2016    

Canadian Consortium on Neurodegeneration in Aging Investments < €500k United Kingdom 2016    

Repressor Element 1-Silencing Transcription Factor (REST): A blood-based biomarker for Alzheimer’s disease linking molecular neuropathology with psychological stress Investments < €500k United Kingdom 2016    

Molecular mechanisms of C9ORF72 repeat expansion toxicity in frontotemporal dementia Investments < €500k United Kingdom 2016    

A PK11195 PET Study of neuroinflammation in dementia with Lewy bodies Investments < €500k United Kingdom 2016    

The molecular basis of the innate response to oligomers of beta amyloid and alpha synuclein Investments < €500k United Kingdom 2016    

Live cell tracking of amyloidogenic species related to Alzheimer’s disease Investments < €500k United Kingdom 2016    

Developing a new biomarker for the early diagnosis of dementia; a novel nonlinear signal processing approach using resting state EEG. Investments < €500k United Kingdom 2016    

Effect of Tat-N-Dimer in Neural Protection and Memory in Amyloid Beta Peptide 1-42 Based Alzheimer’s Model Investments < €500k Turkey 2016    

MALDI-MS Imaging of Proteins in Neurodegenerative Brain Tissue Investments < €500k Turkey 2016    

Development of Florescent Probes for Detection of Amyloid Fibrilles Investments < €500k Turkey 2016    

Study Of Axially Coordinated Phthalocyanines as Anti-Fibrilogenic Agents and Sers-Probes For Amyloid Aggregates Detection Investments < €500k Turkey 2016    

Assessment of Genetic Risk Factors in Alzheimer’s Disease Investments < €500k Turkey 2016    

Remote Monitoring of Parkinson’s Patients Investments < €500k Turkey 2016    

The Role of Apigenin in Cytokine Answer in Parkinson’s Rat Model Investments < €500k Turkey 2016    

Amyloid Beta Aggregation Inhibition of 1,3-benzoxazol-2(3H) Compounds Investments < €500k Turkey 2016    

MR Imaging Based Biomarkers in Mild Cognitive Disorders in Parkinson’s Disease Investments < €500k Turkey 2016    

The Role of Kisspeptin GPR54+ in Patagonesis of Alzheimer’s Disease Investments < €500k Turkey 2016    

Implicit Memory in Cerebellar Ataxia Patients Investments < €500k Turkey 2016    

Association between vitamin D receptor gene polymorphism and Alzheimer’s disease Investments < €500k Turkey 2016    

Bilateral Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Patients Investments < €500k Turkey 2016    

Default Mode Short Term Memory Retention in Mild Cognitive Disorder in Early Alzheimer Patients Investments < €500k Turkey 2016    

Synthesis and Molecular Modelling of Piperidin Hydrazide as a Potential Anti-Alzheimer Compound Investments < €500k Turkey 2016    

Biomarkers in Mild Cognitive Disorder to Dementia in Parkinson’s Disease Investments < €500k Turkey 2016    

Effect of Kynurenic Acid in Beta Amyloid Neurotoxicity Investments < €500k Turkey 2016    

Metabolic Syndrome and Alzheimer’s Disease Investments < €500k Turkey 2016    

FEZ1 Gene Expression in Rat Model of Alzheimer Pathogenesis Investments < €500k Turkey 2016    

Effect of Vitamin D and miRNA125b in Alzheimer’s Disease Pathogenesis Investments < €500k Turkey 2016    

Antibodies as a tool to investigate prion protein toxicity Investments < €500k Switzerland 2016    

Understanding C9ORF72: a novel player in the pathology of ALS/ FTLD Investments < €500k Switzerland 2016    

Characterization of genetic pathways mediating synapse dysfunction in a Drosophila Alzheimer´s disease model Investments < €500k Switzerland 2016    

A novel diagnostic approach for Alzheimer´s disease based on the prion-like properties of tau Investments < €500k Switzerland 2016    

Early synaptic dysfunctions in HD model: role of GluN3A Investments < €500k Switzerland 2016    

Traces towards dementia: Identifying neuronal subpopulations and pathogenic mechanisms at presymptomatic stages of Alzheimer´s disease in a new mouse model Investments < €500k Switzerland 2016    

Cellular-level Signatures of Pre-Symptomatic Neurodegenerative Disease Progression: Hyperpolarized Magnetic Resonance and Correlated TEM/NanoSIMS Imaging Investments < €500k Switzerland 2016